In contrast, some research indicated pharmacological strategies to reduce ACE-2 expression, such as using ursodeoxycholic acid (UDCA) to reduce the infection rate of SARS-CoV-2 by targeting the farnesoid X receptor (FXR) [279]. This evidence concerns the gene ACE2 and infection.